Philbin, Sarah E.
Gleason, Lacey P.
Persell, Stephen D.
Walter, Eve
Petito, Lucia C.
Tibrewala, Anjan
Yancy, Clyde W.
Beidas, Rinad S.
Wilcox, Jane E.
Mutharasan, R. Kannan
Lloyd-Jones, Donald
O’Brien, Matthew J.
Kho, Abel N.
McHugh, Megan C.
Smith, Justin D.
Ahmad, Faraz S. https://orcid.org/0000-0002-2613-2541
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (K23HL155970)
Article History
Received: 1 November 2024
Accepted: 7 April 2025
First Online: 5 May 2025
Declarations
:
: Dr. Ahmad reports receiving research support from Pfizer, Atman Health, Tempus, and AstraZeneca; consulting fees from Alnylam Pharmaceuticals; and honoraria from AstraZeneca outside of the submitted work. Dr. Persell receives research funding paid to Northwestern University from Omron Healthcare Co. Ltd. outside of the submitted work. Dr. Beidas is principal at Implementation Science & Practice, LLC. She is currently an appointed member of the National Advisory Mental Health Council and the NASEM study, “Blueprint for a national prevention infrastructure for behavioral health disorders,” and serves on the scientific advisory board for AIM Youth Mental Health Foundation and the Klingenstein Third Generation Foundation. She has received consulting fees from United Behavioral Health and OptumLabs. She previously served on the scientific and advisory board for Optum Behavioral Health and has received royalties from Oxford University Press. All activities are outside of the submitted work.